Appeal No. 1999-2200 Application No. 08/896,063 Those nucleotide sequences are the inherent properties of cDNAs which existed in the prior art. The prior art of record provided compositions containing those cDNAs in the form of … cDNA libraries…. It further provided analogous compositions and the means and motivation to isolate from those libraries a cDNA of the instant invention. Because a chemical compound and all of its properties are inseparable, and the sequence of a cDNA encoding human GluR3 was an inherent property of that compound as it existed prior to being isolated by [a]ppellant, that limitation was fairly taught by the combination of references cited above. We note the examiner’s use of “GluR3” instead of either GluR3A or GluR3B. This is apparently because the examiner’s combination of references fails to teach GluR3A (SEQ ID NO:1) or GluR3B (SEQ ID NO:3). See specification, page 3, for definition of SEQ ID NOs: 1 & 3 as GluR3A and GluR3B respectively. Here, the examiner has failed to meet his burden of establishing a prima facie case of obviousness for either of the specifically claimed sequences. We see no teaching in the combination of prior art relied upon by the examiner which teaches, suggests or renders the specifically claimed sequences prima facie obvious. It is the examiner who has the initial burden of establishing unpatentability. In re Oetiker, 977 F.2d 1443, 1446, 24 USPQ2d 1443, 1445 (Fed. Cir. 1992). Conclusions of obviousness must be based upon facts, not generality. In re Warner, 379 F.2d 1011, 1017, 154 USPQ 173, 178 (CCPA 1967), cert. denied, 389 U.S. 1057 (1968); In re Freed, 425 F.2d 785, 788, 165 USPQ 570, 571 (CCPA 1970). Where the examiner fails to establish a prima facie case, the rejection is improper and will be overturned. In re Fine, 837 F.2d 1071, 1074, 5 USPQ2d 1596, 1598 (Fed. Cir. 1988). Having determined that the examiner has not established a prima facie case of obviousness, we find it unnecessary to discuss the Zimmerman Declaration 77Page: Previous 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 NextLast modified: November 3, 2007